Predict your next investment

Corporation
HEALTHCARE | Drug Development
catabasis.com

See what CB Insights has to offer

Stage

PIPE | IPO

Total Raised

$103.49M

Market Cap

0.06B

Stock Price

4.42

About Catabasis Pharmaceuticals

Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's drug development programs are rooted in the principles of Pathway Pharmacology, the treatment of diseases by simultaneously modulating more than one target in a disease pathway. Using its SMART (Safely Metabolized And Rationally Targeted) linker technology, we conjugate two drugs that act on different components of a disease pathway to produce new chemical entities with improved safety, tolerability and significantly enhanced efficacy. This approach has allowed Catabasis to move rapidly from concept to investigational new drug (IND) application, and to produce new medicines with superior efficacy.

Catabasis Pharmaceuticals Headquarter Location

One Kendall Square Bldg 1400E Suite B14202

Cambridge, Massachusetts, 02139,

United States

617-349-1971

Latest Catabasis Pharmaceuticals News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Catabasis Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Catabasis Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,533 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Catabasis Pharmaceuticals Patents

Catabasis Pharmaceuticals has filed 52 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Autoimmune diseases
  • Diabetes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/25/2015

4/9/2019

Rare diseases, Fatty acids, Olfactory receptors, Cell biology, Cystic fibrosis

Grant

Application Date

11/25/2015

Grant Date

4/9/2019

Title

Related Topics

Rare diseases, Fatty acids, Olfactory receptors, Cell biology, Cystic fibrosis

Status

Grant

Catabasis Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Catabasis Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.